Therefore, although the effect on prolactin levels was relatively mild and limited to patients with elevated prolactin levels, metformin may be useful in hyperprolactinaemic patients at high risk of diabetes and cardiovascular disease. This evidence concerns the gene PRL and cardiovascular disorder.